as exposure to artificial UV light (such as visits in the solarium). The presence of fading in single hairs of the strand or its ends should also be noted. Because of the rapid decrease in cannabinoid constituents in hair exposed to UV radiation, the result from a particular sample might be rather of a qualitative nature, and a negative finding may not conclusively indicate that there was no cannabis use. At present, it seems a real challenge to identify degradation products of THC, CBN, and CBD as markers for a positive cannabis test in hair. Such work is in progress.
Increased serum LDL-cholesterol (LDL-C) is associated with increased risk for ischemic heart disease, and lowering of LDL-C has been shown to decrease mortality in patients with known coronary heart disease (1) (2) (3) . Persons with diabetes have a greatly increased risk for atherosclerosis and its complications. Many of these patients have increased plasma cholesterol (including LDL-C) and triglycerides (TGs). Additionally, glycation and oxidation of circulating LDL particles may further increase the risk for atherosclerotic disease in patients with diabetes (4, 5 ) .
Currently used methods for LDL-C include calculations [based on total cholesterol (TC), HDL-cholesterol (HDL-C), and TG concentrations], ultracentrifugation, and most recently, direct LDL-C assays. Calculation methods, such at the Friedewald formula (6 ) , are well known to have a prominent negative bias in patients with TG concentrations Ͼ4.5 mmol/L (400 mg/dL) (6, 7 ) . In addition, because TGs are measured, fasting blood samples are preferred. This can present a problem for certain patient populations, including many people with diabetes. Ultracentrifugation methods are time-consuming and expensive and generally are performed only in reference laboratories.
Direct LDL-C assays have been developed recently and have been shown to provide accurate and precise measurements of LDL-C (8 -12 ) . They overcome the TG and fasting limitations of calculation methods, are readily adapted to clinical laboratories, are less expensive than ultracentrifugation methods, and provide greatly improved turnaround time. Direct LDL-C assays make use of either an immunoseparation step or specific detergents to separate LDL particles from other lipoproteins, followed by measurement of cholesterol by conventional enzymatic reactions. The N-geneous TM LDL-C assay is a solute-based homogeneous assay that agrees well with ultracentrifugation (11 ) . The purpose of the present study was to evaluate the effect of glycemic control (as gauged by hemoglobin A 1c ) on the accuracy of the N-geneous assay. Additionally, we compared this direct LDL-C assay to density gradient ultracentrifugation (13 ) and to the Friedewald calculation (6 ), and assessed its usefulness in determining a calculated VLDL-cholesterol (VLDL-C) concentration.
Overnight fasting plasma samples were obtained from 52 patients. Direct LDL-C was measured using the Ngeneous LDL-C assay (Genzyme Diagnostics) performed on the Beckman SYNCHRON LX 20 (Beckman-Coulter).
Briefly, this assay involves a two-reagent process. The first reagent is a detergent that solubilizes only non-LDL lipoprotein particles. The solubilized cholesterol is consumed in a non-color-producing reaction by cholesterol esterase and cholesterol oxidase. The second reagent is then added, which solubilizes the remaining LDL particles and links the enzymatic consumption of LDL-C to a chromogenic coupler. The colored product is measured spectrophotometrically.
TC and TG concentrations were measured using enzymatic methods on the SYNCHRON LX System. HDL-C was measured with Beckman-Coulter reagents on the SYNCHRON LX System, which uses a detergent that solubilizes only HDL particles, allowing HDL-C to be measured by a color-producing enzymatic reaction. An estimated LDL-C concentration was obtained using the Friedewald calculation (6 ): TC Ϫ (HDL-C ϩ TG/5). VLDL-C concentrations were estimated using TG/5, and were also calculated using the direct LDL-C measurement in the formula: VLDL-C ϭ TC Ϫ (HDL-C ϩ LDL-C). LDL-C and VLDL-C were also measured by the Vertical Auto Profile (VAP) technique (Atherotech) (13 ) . Briefly, VAP uses density gradient ultracentrifugation to separate lipoproteins, with subsequent measurement of cholesterol in each of the resulting density bands. Hemoglobin A 1c was measured by HPLC (TOSOH A1C2.2) on diabetic patients (41 of the 52 samples) (14, 15 ) . On all 52 plasma samples, correlation studies were performed comparing LDL-C measurements by the N-geneous LDL-C assay with those from the ultracentrifugation (VAP) technique (13 ) and Friedewald calculation (6 ) .
Linearity of the direct LDL assay was assessed with a patient plasma sample determined to have a LDL-C concentration of 2400 g/L. The following dilutions, in normal saline, were measured: 1:1, 1:2, 1:4, 1:8, 1:16, 1:32, 1:64, and 1:128. Within-run precision studies used a serum-based control (Liquichek Lipid Control level 1; Bio-Rad Laboratories) and the N-geneous LDL-C lyophilized serum calibrator (Genzyme). Between-run precision studies used Bio-Rad Liquichek Lipid Control level 1 and level 2. Within-day precision was assessed on 20 consecutive assays, whereas between-day precision was determined from data obtained in triplicate over 20 separate days. Interference studies were performed on a patient sample with a TG concentration of 28 mmol/L (2490 mg/dL). Direct LDL-C measurements were obtained from the undiluted sample as well as from 1:2, 1:4, 1:8, and 1:16 dilutions of the sample in normal saline.
Statistical analyses and graphing of results were performed using Microsoft Excel 97 SR-2.
For the 52 patients, the ranges and means for TGs, TC, HDL-C, and direct LDL-C were as follows: TGs, range, The results obtained from the N-geneous direct LDL-C assay demonstrated acceptable correlation with the reference (VAP) LDL-C measurements: R 2 ϭ 0.92; y-intercept ϭ 0.06 mmol/L (2.5 mg/dL); slope ϭ 0.96; S y͉x ϭ 0.24 mmol/L (9.1 mg/dL). A small negative bias was identified at lower hemoglobin A 1c concentrations, but no significant bias was identified with hemoglobin A 1c up to 10.3% (Fig. 1A) . As expected, the Friedewald LDL-C showed a prominent negative bias at TG concentrations Ͼ4.5 mmol/L (400 mg/dL), whereas the direct LDL-C measurement showed minimal bias throughout the range of patient TG concentrations (Fig. 1B) .
The estimated VLDL-C (TG/5) compared with the VAP VLDL-C demonstrated an increasingly positive bias (up to 45%) with increasing TG concentrations, whereas VLDL-C calculated using the measured direct LDL-C, HDL-C, and TC concentrations showed little bias when compared with VAP VLDL-C over the same TG range (data not shown). Correlation between the calculated VLDL-C and the VAP VLDL-C was fair: R 2 ϭ 0.77; slope ϭ 0.93; y-intercept ϭ 0.03 mmol/L (1.1 mg/dL); S y͉x ϭ 0.23 mmol/L (8.9 mg/dL).
On the basis of the results of serial dilutions of 6.2 mmol/L (240 mg/dL) LDL-C, the N-geneous assay demonstrated good linearity for LDL-C concentrations of 0.8 -6.2 mmol/L (30 -240 mg/dL). Acceptable recoveries (91.1-99.6%) were obtained throughout this range. Within-day precision data obtained using the Bio-Rad level 1 control showed a mean of 1.6 mmol/L (61 mg/dL) with a CV of 1.4%, whereas the Genzyme calibrator sample yielded a mean of 2.5 mmol/L (95 mg/dL) with a CV of 1.3%. Between-day precision on the Bio-Rad level 1 control demonstrated a mean of 1.6 mmol/L (60 mg/dL) with a CV of 1.5%, whereas the Bio-Rad level 2 control showed a mean of 3.3 mmol/L (125 mg/dL) and a CV of 1.4%. No interference with the direct LDL-C assay was observed at TG concentrations of 1.8 -14.1 mmol/L (156 -1245 mg/ dL). Throughout this range, the maximum deviation of any individual measurement from the mean was Ͻ7%. However, we observed a negative bias of 78% at a TG concentration of 28.1 mmol/L (2490 mg/dL).
Methods for the direct measurement of LDL-C are now readily available to hospital and commercial laboratories. These assays involve either immunoseparation or detergent separation of LDL-C from other lipoprotein-associated cholesterol. As a whole, these assays have been well studied and compared to the indirect calculation and ultracentrifugation techniques of determining LDL-C concentration (8 -12 ) , and have generally shown good correlation with both methods. In the present study, we found good correlation of the N-geneous direct LDL-C assay with the Friedewald calculation at TG concentrations Ͻ2.3 mmol/L (200 mg/dL; data not shown) and with the VAP density gradient ultracentrifugation technique. We also demonstrated a prominent negative bias in the Friedewald calculation, but not in the direct LDL-C method, compared with the VAP LDL-C at TG concentrations Ͼ4.5 mmol/L (400 mg/dL). No interference with the N-geneous assay was observed at TG concentrations up to 14.1 mmol/L (1245 mg/dL), a point at which the TG concentrations would override the LDL-C in clinical importance because of the risk of acute pancreatitis. The assay showed good linearity from LDL-C concentrations of 0.8 -6.2 mmol/L (30 -240 mg/dL), and both within-day and dayto-day precision were excellent. These findings are consistent with a previous report evaluating the N-geneous LDL-C assay (11 ) .
Situations where a direct LDL-C measurement appear to be preferable to a calculated LDL-C value include patients with TGs Ͼ4.5 mmol/L (400 mg/dL) and patients who are unable to fast (6, 7 ) . Often persons with diabetes will fall into one or both of these categories and will likely represent a large group on whom direct LDL-C assays will be used. Persons with diabetes often have increases in altered forms of LDL particles, such as glycated LDLs and oxidized LDLs (4, 5 ) . It was therefore important to assess what effect, if any, glycemic control has on the ability of a direct LDL assay to accurately measure LDL-C. Our data show that the N-geneous direct LDL assay shows no significant bias associated with increasing hemoglobin A 1c up to 10.3% as measured by HPLC.
In the present study, we also compared estimated and calculated VLDL-C concentrations to those measured via the VAP procedure. As expected, estimating VLDL-C by dividing the TG concentration by 5 showed a positive bias that became more prominent as the TG concentration increased. Calculating VLDL-C yielded little average bias when compared with VAP VLDL-C; however, a few individual calculated values showed larger biases, up to 150%. These large biases were most pronounced at lower VLDL-C concentrations, where they would be less clinically significant. Additionally, there was fair correlation between the calculated and VAP VLDL-C values. The exact significance of VLDL-C as a clinically important risk factor for atherosclerosis remains controversial, and calculated VLDL-C may be inaccurate in the presence of lipoproteins such as intermediate-density lipoproteins and lipoprotein(A), for example. Nevertheless, a calculated VLDL-C value may be useful in clinical and research settings.
In conclusion, the N-geneous direct LDL-C assay shows good correlation with the VAP ultracentrifugation method of measuring LDL-C and does not appear to be affected by glycemic control or TGs Ͼ4.5 mmol/L (400 mg/dL), supporting its usefulness in diabetic patients. Capillary electrophoresis (CE) achieves efficient separation of molecular species by the application of high voltages to samples in solution (1 ) . Commercial CE units, available for slightly more than a decade, have found numerous applications (2-6 ), but are expensive (ϳ$60 000) and require substantial user training and experience. Recent advances have allowed CE to be performed on microchip devices (7) (8) (9) (10) (11) . We evaluated the Agilent 2100 Bioanalyzer (Agilent Technologies), which represents a new generation of CE instruments that use this technology.
Evaluation of DNA Fragment Sizing and
The Bioanalyzer is relatively inexpensive (ϳ$18 000) and is simple to operate, requiring only routine pipetting and basic computer skills. Typically, 12 nucleic acid samples can be sized and quantified on a disposable chip within 30 min. Chips are fabricated from glass and comprise an interconnected network of fluid reservoirs and microchannels, which must be filled with a gel-dye mixture. Each chip contains 16 wells: 3 for loading the gel-dye mixture, 1 for a molecular size ladder, and 12 for experimental samples. The movement of nucleic acids through the microchannels is controlled by a series of electrodes, each of which is independently connected to a common power supply. The Bioanalyzer displays data as both migration-time plots and as computer-generated virtual gels. Traditional CE operating variables [temperature, voltage, capillary material, and pH, ionic strength, and viscosity of buffer (12 ) ] cannot be modified. The instruments costs ϳ$18 000, and chips cost ϳ$12-18 per chip ($1-1.50 per sample).
The gel-dye mixture consists of a linear polymer and a fluorescent, intercalating dye. The marker mixture consists of a buffer along with lower and upper molecular size markers, which the Bioanalyzer uses as references when sizing DNA fragments. The upper marker is also used as a reference for calculating the concentration of DNA fragments in each sample. Each reagent set also contains a molecular size ladder for sizing experimental DNA fragments.
We evaluated the ability of the Agilent 2100 Bioanalyzer (Biosizing software, Ver. A.01.05) to generate consistent results with respect to sizing and signal quantification on a well-to-well, chip-to-chip, and day-to-day basis, using PCR fragments and commercially available plasmid digests.
Whole blood was obtained from healthy volunteers and drawn into EDTA-coated tubes. Genomic DNA was purified directly from whole blood using the QIAamp DNA Blood Mini reagent set (Qiagen) and resuspended in DNase-free water. Gene-specific primers for endothelial nitric oxide synthase (eNOS) (13 ) yielded a 379-bp fragment (forward primer, 5Ј-GTG ATG GCG AAG CGA GTG AAG-3Ј; reverse primer, 5Ј-GAC ACC ACG TCA TAC TCA TCC-3Ј). Amplification of eNOS DNA was achieved using a GeneAmp 2400 PCR System (PerkinElmer) and AmpliTaq Gold (Perkin-Elmer) under the following conditions: 10-min activation of Taq enzyme at 95°C, followed by 45 cycles of 94°C for 30 s (to denature), 65°C for 30 s (to anneal), and 72°C for 30 s (to extend). All reaction volumes were 50 L. PCR product was concentrated via precipitation using two volumes of cold ethanol (Ϫ80°C, overnight), centrifuged at 14 000g for 5 min, washed once with cold ethanol (950 mL/L), aspirated, allowed to dry under ambient conditions, and resuspended in DNase-free water. Removal of primers, nucleotides, and salts was accomplished using the QIAquick PCR purification method (Qiagen). The final elution of PCR product was performed with Tris-EDTA buffer to a final concentration of ϳ40 ng/L. The concentrations of eNOS PCR samples were determined via absorbance readings at 260 nm using a SmartSpec 3000 spectrophotometer (Bio-Rad).
DNA 7500 Lab Chips (Agilent Technologies) were loaded with samples as recommended by the manufacturer with minor modifications. Briefly, microchannels were filled by pipetting 9 L of gel-dye mixture into the appropriate well and then forcing the mixture into the microchannels by applying pressure to the well via a 1-mL syringe. The ladder well and sample wells were subsequently loaded with 5 L of marker mixture plus 1 L of either molecular size ladder or sample, respectively, using one of four protocols: (protocol A) 5 L of marker mixture was loaded into each sample well, followed by 1 L of sample; chips were vortex-mixed at setting 5 for 1 min in a Fisherbrand Vortex Genie-2 (Fisher Scientific); (protocol B) same as (A) except that the chips were vortex-mixed at setting 4; (protocol C) 66 L of marker mixture and 13 L of sample were mixed in a microfuge tube; 6 L of this mixture was loaded into each sample well; chips were vortex-mixed at setting 4 for 1 min; (protocol D) marker mixture was loaded into each sample well, followed by 1 L of sample; the contents of each well on the chip were gently pipetted three times in situ using a P10 Pipetman; chips were vortex-mixed at setting 4 for 1 min. After being vortex-mixed, chips were immediately
